Cite
HARVARD Citation
Kalinsky, K. et al. (2017). A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607). Cancer. 123 (14), pp. 2688-2697. [Online].